Pain Associated with Ocular Inflammation

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-09-03
Clinical Trial Update: Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery [Phase 3]
Phase 3 trial of mapracorat ophthalmic suspension 3% for ocular inflammation after cataract surgery was terminated; results posted in 2020.